Home LiteratureArticle Details
PMID: 10978887 Published · ppublish English Journal Article Review

Avidity regulation of integrins: the driving force in leukocyte adhesion.

Current opinion in cell biology ·Vol. 12 ·No. 5 ·2000-10-00 ·Pages 542-7

van Kooyk Y, Figdor CG

Abstract

The activity of integrins on leukocytes is tightly controlled, and their adhesion capacity shifts rapidly when cells emigrate from the blood to the tissues. The leukocyte-specific beta2 integrin LFA-1 (alphaLbeta2) is the most important integrin expressed by leukocytes that regulate lymphocyte migration and the initiation of an immune response through binding to ICAM-1,-2 or-3. The binding activity of LFA-1 is rapidly altered by intracellular stimuli that activate LFA-1. Although alterations in the affinity of LFA-1, which leads to enhanced ICAM-1 binding, have been proposed, evidence is emerging that dynamic reorganisation of LFA-1 into microclusters is the major mechanism that regulates its binding capacity.

MeSH Terms
Animals Binding, Competitive Cell Adhesion Cell Adhesion Molecules/metabolism Cytoskeleton/metabolism Humans Leukocytes/cytology,metabolism Lymphocyte Function-Associated Antigen-1/metabolism
Chemicals
Cell Adhesion Molecules Lymphocyte Function-Associated Antigen-1
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
van Kooyk Y
Department of Tumor Immunology, University Medical Center Nijmegen, St Radboud, P. Van Leydenlaan 25, 6525 EX, the, Nijmegen, Netherlands. Y.vanKooyk@dent.kun.nl
Figdor C G
Article Info
Journal
Current opinion in cell biology
Abbr.
Curr Opin Cell Biol
ISSN
0955-0674
Published
2000-10-00
Pages
542-7
Language
English
Region
England
NLM ID
8913428
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com